Scipibaimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Scipibaimab, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]